Cannabis-related disorders, hospitalization, and cardiovascular outcomes in patients with heart failure: A real-world propensity-matched cohort study
BACKGROUND: The clinical implications of cannabis exposure in patients with heart failure remain uncertain. We evaluated the associations between a documented cannabis-related disorder (CRD) and hospitalization and cardiovascular outcomes in a large real-world heart failure cohort. METHODS: We performed a retrospective cohort study using the TriNetX US Collaborative Network. Adult patients with heart failure (ICD-10-CM I50) were identified and stratified by the presence or absence of cannabis-related disorder (ICD-10-CM F12) recorded within 1 year on or before the first heart failure diagnosis, which served as the index date. The primary outcome was all-cause hospitalization at 1 year. Secondary outcomes included stroke, myocardial infarction, end-stage renal disease, atrial fibrillation/flutter, and all-cause mortality. Follow-up began 1 day after the index date; patients with a prior history of a given outcome were excluded from that analysis. One-to-one propensity score matching was performed using 26 baseline covariates. RESULTS: After matching, 30,624 patients were included in each cohort. At 1 year, a documented CRD was associated with a higher risk of hospitalization (57.5% vs. 45.1%; HR, 1.468; 95% CI, 1.436-1.501; p < 0.001). A documented CRD was also associated with significantly higher all-cause mortality (10.4% vs 9.3%; HR, 1.147; 95% CI, 1.090-1.207; p < 0.001), stroke (2.9% vs 2.3%; HR, 1.263; 95% CI, 1.138-1.401; p < 0.001), and myocardial infarction (6.0% vs 4.4%; HR, 1.415; 95% CI, 1.307-1.531; p < 0.001). Atrial fibrillation/flutter and end-stage renal disease did not differ. The hospitalization association persisted after excluding the first 30 days of follow-up (HR 1.252; 95% CI 1.226-1.280; p < 0.001), was similar in women and men, and remained in multivariable Cox models (adjusted HR 1.521; 95% CI 1.503-1.539; p < 0.001). CONCLUSIONS: In this real-world propensity score-matched cohort of patients with heart failure, a documented cannabis-related disorder was associated with higher risks of hospitalization and selected adverse cardiovascular outcomes. Prospective studies with precise cannabis exposure characterization are needed to confirm these associations.
Authors
- Aabha Divya (ORCID: https://orcid.org/0000-0001-8289-1369)
- Mrudula R. Munagala (ORCID: https://orcid.org/0000-0003-1937-7468)
- Sapna Desai (ORCID: https://orcid.org/0009-0000-4872-8381)
- Heeran S. Karim
- Ruben J. Azocar
- Niti Dalal (ORCID: https://orcid.org/0000-0003-4283-4989)
- Dani S. Bengoa
- Mark Sanadi
Institutions
- Tulane University (US)
- University of Miami (US)
Publication Details
- Journal
- Clinical Research in Cardiology
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s00392-026-03056-5
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00